Beijing Succeeder Technology Inc. researches, develops, produces, and sells testing instruments, reagents, and consumables for in vitro diagnostics in thrombosis and hemostasis. Its offerings include coagulation testers, hemorheology testers, erythrocyte sedimentation rate and hematocrit testers, platelet aggregation testers, blood rheology analyzers, diagnostic reagents, quality control products, and automated equipment with supporting testing instruments. These products are used in the prevention, screening, diagnosis, and monitoring of thrombophilia and hemorrhagic diseases such as stroke, coronary heart disease, and venous thromboembolism. Founded in 2003, the company is based in Beijing, China, and operates domestically and internationally.